Is hydroxyzine safe for pediatric patients to treat anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydroxyzine Safety for Pediatric Anxiety Treatment

Hydroxyzine can be used as a second-line treatment for anxiety in pediatric patients, but SSRIs and cognitive behavioral therapy should be considered first-line options due to stronger evidence for long-term efficacy and safety. 1

Efficacy and Safety Profile

Hydroxyzine is FDA-approved for the symptomatic relief of anxiety and tension associated with psychoneurosis, though its long-term effectiveness (beyond 4 months) has not been assessed by systematic clinical studies 2. The American Academy of Child and Adolescent Psychiatry recommends SSRIs and SNRIs as first-line pharmacotherapy for anxiety disorders, with hydroxyzine considered a second-line option 1.

Safety Considerations:

  • Short-term use: Hydroxyzine is generally safe for short-term management of anxiety in pediatric patients, particularly for anxiolysis during medical procedures 3

  • Long-term concerns: A 2021 population-based longitudinal study found that frequent hydroxyzine use in children under 5 years was associated with higher rates of:

    • Tic disorders (OR 1.55)
    • Anxiety (OR 1.34)
    • Conduct disturbances (OR 1.34)
    • Non-significant increased trends for ADHD and emotional disturbances 4
  • Side effects: Common side effects include:

    • Sedation/drowsiness (most common)
    • Potential anticholinergic effects
    • Potential QT prolongation (rare but serious) 2

Treatment Algorithm for Pediatric Anxiety

First-Line Options:

  1. Cognitive behavioral therapy (CBT) - Highly effective and recommended either alone or in combination with medication 1

  2. SSRIs (if pharmacotherapy needed):

    • Fluoxetine
    • Sertraline
    • Escitalopram
    • These have stronger evidence for long-term efficacy 1, 5

Second-Line Options:

  1. Hydroxyzine - Consider when:

    • Rapid anxiolysis is needed
    • First-line treatments are ineffective or contraindicated
    • Short-term management is appropriate 1
  2. SNRIs (e.g., venlafaxine) - Comparable efficacy to SSRIs 1

Dosing and Administration Considerations

When using hydroxyzine in pediatric patients:

  • Start with the lowest effective dose
  • Use for the shortest duration possible to minimize potential neurodevelopmental effects 4
  • Monitor for sedation, which may affect school performance
  • Avoid combining with other CNS depressants as hydroxyzine potentiates their effects 2

Important Precautions

  • Drug interactions: Hydroxyzine potentiates CNS depressants (narcotics, analgesics, barbiturates) - dosage reduction of these medications may be necessary 2

  • Cardiac considerations: Use with caution in patients with risk factors for QT prolongation or concomitant medications known to prolong QT interval 2

  • Driving/machinery: Warn patients about potential drowsiness and caution against driving or operating dangerous machinery 2

  • Monitoring: Regular reassessment of the medication's usefulness is recommended, especially for long-term use 2

Conclusion

While hydroxyzine can be used for pediatric anxiety, the evidence suggests it should be reserved as a second-line option after SSRIs and CBT. The 2021 longitudinal study raising concerns about potential neurodevelopmental effects with frequent use 4 suggests that hydroxyzine should be used for the shortest possible duration in children, particularly in preschool-aged patients.

References

Guideline

Anxiety Disorder Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.